ABFmulti: Anatomy-Based Fitting in Unexperienced Cochlear Implant Users

Sponsor
Universitair Ziekenhuis Brussel (Other)
Overall Status
Recruiting
CT.gov ID
NCT05451628
Collaborator
(none)
40
1
2
18.1
2.2

Study Details

Study Description

Brief Summary

Severe to profound hearing loss affects 0,8% of the global population. For these people, a conventional hearing aid often does not provide sufficient benefit. However, these people can benefit from a cochlear implant (CI). A CI needs to be individually programmed (fitted) for each recipient. A fitting "map" is defined as a set of electrical parameters that are individually adapted to a recipient's needs to achieve optimal sound perception. At present, most CI recipients are fitted with a default frequency allocation map that doesn't take individual variability in size and shape of the cochlea into account. In this study, a fitting strategy based on the post-operative CT scan, that will allow the audiologist to set a frequency-band distribution for CI fitting that may be more closely aligned to the natural tonotopic frequency distribution of a normal hearing cochlea, will be evaluated.

Condition or Disease Intervention/Treatment Phase
  • Device: Default CI fitting
  • Device: Anatomy-based CI fitting
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Anatomy-Based Fitting in Unexperienced Cochlear Implant Users
Actual Study Start Date :
Mar 30, 2022
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Oct 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Default CI fitting

Programming of cochlear implant speech processor according to standard clinical care

Device: Default CI fitting
Programming of cochlear implant speech processor according to standard clinical care

Active Comparator: Anatomy-based CI fitting

Programming of cochlear implant speech processor with anatomy-based fitting

Device: Anatomy-based CI fitting
Programming of cochlear implant speech processor with anatomy-based fitting

Outcome Measures

Primary Outcome Measures

  1. Speech recognition test in quiet (S0): percentage correctly identified phonemes [3 months post-activation]

  2. Speech recognition test in quiet (S0): percentage correctly identified phonemes [6 months post-activation]

Secondary Outcome Measures

  1. Speech recognition test in noise (S0N0): the speech reception threshold in dB SNR [3 months post-activation]

  2. Speech recognition test in noise (S0N0): the speech reception threshold in dB SNR [6 months post-activation]

  3. Result of the pitch matching test: frequency difference in semitones [3 months post-activation]

  4. Result of the pitch matching test: frequency differences in semitones [6 months post-activation]

  5. Result of the perception of timbre test: Score on Visual Analog Scale (VAS) [3 months post-activation]

    Patients have to rate the timbre on a visual analog scale (VAS) ranging from 0 to 10, where a higher score reflects a better outcome.

  6. Result of the perception of timbre test: Score on Visual Analog Scale (VAS) [6 months post-activation]

    Patients have to rate the timbre on a visual analog scale (VAS) ranging from 0 to 10, where a higher score reflects a better outcome.

  7. Result of the consonance and dissonance rating test: Plot of pleasantness over frequency interval and modulation measure [3 months post-activation]

  8. Result of the consonance and dissonance rating test: Plot of pleasantness over frequency interval and modulation measure [6 months post-activation]

  9. Result of the speech contrast discrimination test: Psychometric function of phoneme categorization [3 months post-activation]

  10. Result of the speech contrast discrimination test: Psychometric function of phoneme categorization [6 months post-activation]

  11. Patient reported outcome- Hearing Implant Sound Quality Index (HISQUI): Total score and classification of self-perceived auditory benefit [1 day visit (At the activation of the sound processor)]

  12. Patient reported outcome- Hearing Implant Sound Quality Index (HISQUI): Total score and classification of self-perceived auditory benefit [3 months post-activation]

  13. Patient reported outcome- Hearing Implant Sound Quality Index (HISQUI): Total score and classification of self-perceived auditory benefit [6 months post-activation]

  14. Datalogging data: Average numbers of hours per day [2 weeks post-activation]

  15. Datalogging data: Average numbers of hours per day [1 months post-activation]

  16. Datalogging data: Average numbers of hours per day [3 months post-activation]

  17. Datalogging data: Average numbers of hours per day [6 months post-activation]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 18 years

  • Post-lingual onset of severe to profound sensory-neural hearing loss in the implanted ear(s)

  • Post-operative Computed Tomography (CT) scan of the CI electrode available

  • Pre-operative result of pure-tone audiometry, speech test in quiet and in noise available

  • Subject implanted with MED-EL cochlear implant(s)

  • Subjects received a Flex28, FlexSoft or Standard electrode

  • Subject planned to receive a SONNET 2 or RONDO 3 audio processor on the newly implanted side

  • Audio processor not yet activated on the newly implanted side

  • The most apical active electrode contact has to be inserted at least 450°

  • Minimum of 10 active channels can be activated

  • Fluent in the language of the test centre

  • Signed and dated Informed Consent Form (ICF) before the start of any study-specific procedure

Exclusion Criteria:
  • Lack of compliance with any inclusion criteria

  • Electric Acoustic Stimulation (EAS) user (user of an EAS audio processor)

  • Implanted with C40+, C40X and C40C

  • Implanted with an Auditory Brainstem Implant (ABI) or Split electrode array

  • Anything that, in the opinion of the Investigator, would place the subject at increased risk or pre-clude the subject's full compliance with or completion of the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 UZ Brussel Brussel Belgium 1090

Sponsors and Collaborators

  • Universitair Ziekenhuis Brussel

Investigators

  • Principal Investigator: Vedat Topsakal, Prof., UZB-VUB

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Universitair Ziekenhuis Brussel
ClinicalTrials.gov Identifier:
NCT05451628
Other Study ID Numbers:
  • EC-2021-437
First Posted:
Jul 11, 2022
Last Update Posted:
Jul 11, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 11, 2022